Search

Search Results

• Pathogenetic features of morphodensitometric characteristics of cardiomyocytes and marker profile of the left ventricular remodeling in rats with experimental intermittent hypoxia of different duration

  Yu. M. Kolesnyk, M. I. Isachenko

  752-762

  2020-09-25
• Expediency of сitoprotective treatment of patients with acute myocardial infarction, who were performed percutaneous coronary intervention

  M. Shved, T. Dobrianskyi, L. Tsuglevich, S. Heryak

  259-271

  2020-02-28
• Mechanisms of ethanol liver damage in rats with different emotionality

  O. A. Коstiuk, O. V. Denefil

  117-130

  2021-01-06
• The Role of Diet and Nutrition in Heart Failure Care

  Mateusz Kasprzak, Kacper Godyń-Müller, Michał Grześkowiak, Hanna Pelant, Martin Zeigner, Joanna Błaszczyk, Bartosz Kulak, Michał Brzeziński, Zuzanna Majchrzak, Klaudia Pierzyńska

  72672

  2026-06-23
• Assessment of the state of intracardiac hemodynamics and myocardial remodeling in women with gonarthritis, hypertension and overweight

  A. Pidlubna

  185-194

  2021-07-29
• Experience of Magnesium and L-Carnitine Combine Use for Correction of Structural and Functional Heart Changes in Type 2 Diabetic Patients with End-Stage Kidney Disease

  Oleksandr Susla, Zoriana Litovkina, Inna Yakubyshyna

  286-303

  2020-12-28
• Ocena skuteczności i bezpieczeństwa farmakoterapii inhibitorami aldosteronu w niewydolności serca = Evaluation of the efficacy and safety of pharmacotherapy using aldosterone antagonists in heart failure

  Agata Tarczykowska, Bartosz Kochański, Łukasz Wołowiec, Agnieszka Surowiec, Anna Plaskiewicz, Walery Zukow

  153-162

  2015-07-05
• Механизмы, клиническая значимость и взаимоотношение тканевого фиброза и фибрилляции предсердий = Mechanisms, clinical significance and relationship of tissue fibrosis and atrial fibrillation = Механізми, клінічна значущість та взаємовідношення тканинного фіброзу і фібриляції передсердь

  A. I. Gozhenko, E. M. Levchenko, V. V. Goriachyi, A. V. Goriachyi

  520-536

  2017-02-10
• Патогенетические механизмы фибрилляции предсердий и формирования предсердного фиброза = Pathogenic mechanisms of atrial fibrillation and atrial fibrosis formation

  A. I. Gozhenko, N. R. Bayazitov, E. M. Levchenko, V. V. Goriachyi, A. V. Goriachyi

  22-33

  2016-10-07
• Angiotensin Receptor Antagonist-Neprilysin Inhibitor (ARNI) therapy as a new hope in the population of people with heart failure with reduced ejection fraction (HFrEF)

  Przemysław Żelazny, Joanna Filipczak, Oliwer Sygacz, Sebastian Bróż, Sara Dankiewicz, Aleksandra Swora, Joanna Borowik, Wojciech Brodowski, Piotr Pawłowski, Katarzyna Basta-Arciszewska

  583-588

  2022-09-08
• Hypertrophic Cardiomyopathy in the Era of Targeted Therapy: The Role of Cardiac Myosin Inhibitors, Contemporary Sudden Cardiac Death Risk Stratification, and the Importance of Differential Diagnosis — A Narrative Review

  Julia Parda, Jakub Bundyra, Dominika Janik, Oliwia Zuzanna Gańska, Agata Sochocka, Zuzanna Zapart, Martyna Szepietowska, Nina Nowicka, Alicja Sikorska, Emil Mian

  72850

  2026-07-13
• Nutritional Insights: How Food Choices Affect Atrial Fibrillation

  Daniel Gondko, Patrycja Dębiec, Jakub Roman, Nikodem Pietrzak

  51691

  2024-06-03
• Atopic condition of the esophagus - eosinophilic esophagitis - literature review

  Artur Pastuszka, Karolina Serwońska, Aleksandra Galanty-Ochyra, Jan Węgrzyn, Adam Czarnecki, Olga Jabłońska, Piotr Zając, Łukasz Fijałkowski, Aleksandra Nosal

  59373

  2025-04-28
• Precision Negative Inotropy: The Rise of Cardiac Myosin Inhibitors in HCM

  Katarzyna Skibicka, Tomasz Skibicki, Weronika Wesołowska, Robert Bujak

  65626

  2025-09-24